Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

Your numbers and knowledge mean absolute squat to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
gixxer11 Member Profile
 
Followed By 48
Posts 5,829
Boards Moderated 1
Alias Born 11/27/11
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/30/2014 9:19:06 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/30/2014 6:03:00 AM
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Ph... "PR Newswire (US)" - 10/28/2014 6:20:00 PM
Arena Pharmaceuticals Announces Third Quarter 2014 Conference Call and Webcast on Monday, November 3 "PR Newswire (US)" - 10/27/2014 8:00:00 AM
Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at the American College of Clinical Pharmacy Ann... "PR Newswire (US)" - 10/13/2014 8:00:00 AM
Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) C... "PR Newswire (US)" - 10/10/2014 11:36:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/9/2014 4:41:48 PM
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference "PR Newswire (US)" - 9/22/2014 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/19/2014 4:49:54 PM
FDA Approves Orexigen's Diet Drug Contrave "Dow Jones News" - 9/11/2014 8:50:11 AM
Lorcaserin HCl Data to be Presented at the American Society of Bariatric Physicians' 64th Annual Obesity & Associated Conditi... "PR Newswire (US)" - 9/10/2014 8:00:00 AM
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension "PR Newswire (US)" - 9/2/2014 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/27/2014 7:52:46 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/6/2014 4:34:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/1/2014 8:18:39 AM
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results "PR Newswire (US)" - 8/1/2014 4:30:00 AM
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obe... "PR Newswire (US)" - 7/30/2014 8:00:00 AM
Eisai and Arena Pharmaceuticals Announce BELVIQ® (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in t... "PR Newswire (US)" - 7/29/2014 8:00:00 AM
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 "PR Newswire (US)" - 7/25/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2014 4:33:20 PM
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Israel "PR Newswire (US)" - 7/21/2014 8:00:00 AM
Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office "PR Newswire (US)" - 7/15/2014 4:31:00 PM
Arena Pharmaceuticals Reports that Eisai Completes Planned Increase in Sales Force for BELVIQ® (lorcaserin HCl) CIV "PR Newswire (US)" - 7/10/2014 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2014 4:38:31 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/27/2014 6:50:01 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist